Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83